Charles R. Kummeth has bought stock on 3 days since Sep 2019

Charles R. Kummeth is an experienced life sciences executive who serves as the independent, non-executive Chairman of the Board at Quantum-Si (QSI), a position he assumed on May 28, 2024( With over 35 years of leadership experience in the life sciences industry, Kummeth brings substantial operational expertise to the company. Most notably, he served as President and Chief Executive Officer of Bio-Techne from April 2013 to February 2024, where he oversaw remarkable growth including annual revenue expansion from $300 million to over $1.1 billion, workforce expansion from 800 to over 3,000 employees, and successful execution of 19 acquisitions while maintaining EBITDA levels of 35% or better( Under his leadership, Bio-Techne's market capitalization grew from $2.2 billion to a peak of $21 billion, culminating in the company's inclusion in the S&P 500(

Kummeth's career also includes significant roles at Thermo Fisher Scientific, where he served as President of Mass Spectrometry and Chromatography and President of the Laboratory Consumables Division from August 2011 to March 2013( Prior to that, he spent approximately 24 years at 3M Corporation in various roles, culminating as Vice President of the Medical Division( He holds a BS in Electrical Engineering from the University of North Dakota, a MS in Computer Science from the University of St. Thomas, and an MBS from the Carlson School of Business at the University of Minnesota( Beyond his role at Quantum-Si, Kummeth serves on the boards of PerkinElmer, Gentherm, and Orthofix, further demonstrating his standing in the life sciences and healthcare sectors(

Written by Perplexity from public sources.